Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AC-150 in allergic conjunctivitis
NCT01134328Phase 2Completed
- Sponsor
- Aciex Therapeutics
- Start
- May 2010
- Primary completion
- Jul 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of cetirizine, fluticasone propionate in allergic conjunctivitis (AC), sponsored by Aciex Therapeutics. Started May 2010; status: completed.
02
Drugs
cetirizinefluticasone propionate
03
Conditions
allergic conjunctivitis (AC)
Beyond the preview
Go deeper on NCT01134328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01134328.